ASIF AHMAD BHAT

Employment

• AIMST University PhD Student and Researcher
  2026 - 2028
• Suresh Gyan Vihar University Assistant professor
  2022 - 2025

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (48)

• Corrigendum "Ferroptosis and circular RNAs: new horizons in cancer therapy"
  EXCLI Journal 2026 DOI: 10.17179/excli2026-9663
  +Save
• Calreticulin mutations in essential thrombocythemia and primary myelofibrosis
  CLINICA CHIMICA ACTA 2026 DOI: 10.1016/J.CCA.2026.121129
  +Save
• FLT3 mutations as diagnostic and prognostic biomarkers in acute myeloid leukemia
  CLINICA CHIMICA ACTA 2026 DOI: 10.1016/J.CCA.2026.121132
  +Save
• Galectin-3 as a cardiac biomarker
  CLINICA CHIMICA ACTA 2026 DOI: 10.1016/J.CCA.2025.120777
  +Save
• JAK2 V617F as a diagnostic and prognostic biomarker in myeloproliferative neoplasms
  CLINICA CHIMICA ACTA 2026 DOI: 10.1016/J.CCA.2026.121116
  +Save
• Transferrin Receptor 1 (TFRC) and Ferroptosis-Related Biomarkers in Oncology: Analytical Evaluation and Translational Potential
  Asif Ahmad Bhat, Riya Thapa, Shivkanya Fuloria +4 more
  CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY 2026 DOI: 10.1080/10408347.2026.2680160
  +Save
• Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC)
  CURRENT CANCER DRUG TARGETS 2025 DOI: 10.2174/0115680096343056240828190900
  +Save
• Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease
  Riya Thapa, Arockia Babu Marianesan, A. Rekha +9 more
  BIOGERONTOLOGY 2025 DOI: 10.1007/S10522-025-10208-Z
  +Save
• The Anticancer Journey of Liquiritin: Insights into Its Mechanisms and Therapeutic Prospects
  Asif Ahmad Bhat, Ehssan H. O. Moglad, Muhammad Afzal +10 more
  CURRENT MEDICINAL CHEMISTRY 2025 DOI: 10.2174/0109298673315699240805111122
  +Save
• The role of CD95 in modulating CAR T-cell therapy: Challenges and therapeutic opportunities in oncology
  Asif Ahmad Bhat, Abdulmalik Saleh Alfawaz Altamimi, Ahsas Goyal +10 more
  INTERNATIONAL IMMUNOPHARMACOLOGY 2025 DOI: 10.1016/J.INTIMP.2024.113675
  +Save
• CRBN-PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
  CHEMICAL BIOLOGY & DRUG DESIGN 2024 DOI: 10.1111/CBDD.70009
  +Save
• CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis
  Asif Ahmad Bhat, Gaurav Gupta, Rajiv Dahiya +11 more
  NON-CODING RNA RESEARCH 2024 DOI: 10.1016/J.NCRNA.2024.01.013
  +Save
• DECIPHERING NF-ΚB PATHWAYS IN SMOKING-RELATED LUNG CARCINOGENESIS
  Riya Thapa, Ehssan H. O. Moglad, Ahsas Goyal +11 more
  EXCLI JOURNAL 2024 DOI: 10.17179/EXCLI2024-7475
  +Save
• Epithelial-mesenchymal transition to mitigate age-related progression in lung cancer
  Riya Thapa, Saurabh Gupta, Gaurav Gupta +7 more
  AGEING RESEARCH REVIEWS 2024 DOI: 10.1016/J.ARR.2024.102576
  +Save
• Exploring ncRNA-mediated pathways in sepsis-induced pyroptosis
  Asif Ahmad Bhat, Yassine Riadi, Muhammad Afzal +12 more
  PATHOLOGY RESEARCH AND PRACTICE 2024 DOI: 10.1016/J.PRP.2024.155224
  +Save
• Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics
  Riya Thapa, Muhammad Afzal, Ahsas Goyal +14 more
  LIFE SCIENCES 2024 DOI: 10.1016/J.LFS.2024.122613
  +Save
• FERROPTOSIS AND CIRCULAR RNAS: NEW HORIZONS IN CANCER THERAPY
  Asif Ahmad Bhat, Neelima Kukreti, Muhammad Afzal +10 more
  EXCLI JOURNAL 2024 DOI: 10.17179/EXCLI2024-7005
  +Save
• From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
  Riya Thapa, Obaid Afzal, Muhammad Afzal +9 more
  PATHOLOGY RESEARCH AND PRACTICE 2024 DOI: 10.1016/J.PRP.2023.154959
  +Save
• MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting
  Asif Ahmad Bhat, Obaid Afzal, Muhammad Afzal +10 more
  PATHOLOGY RESEARCH AND PRACTICE 2024 DOI: 10.1016/J.PRP.2023.154991
  +Save
• Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging
  Asif Ahmad Bhat, Ehssan H. O. Moglad, Ahsas Goyal +11 more
  LIFE SCIENCES 2024 DOI: 10.1016/J.LFS.2024.123056
  +Save